The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 24, 2020

Filed:

Mar. 24, 2015
Applicants:

Yale University, New Haven, CT (US);

Glaxosmithkline Biologicals SA, Rixensart, BE;

Inventors:

Richard Bucala, New Haven, CT (US);

Andrew Geall, Cambridge, MA (US);

Assignees:

Yale University, New Haven, CT (US);

GlaxoSmithKline Biologicals SA, Rixensart, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/015 (2006.01); C07K 14/44 (2006.01); C07K 16/20 (2006.01); C07K 16/24 (2006.01); A61K 9/107 (2006.01); A61K 9/127 (2006.01); C07K 14/445 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/015 (2013.01); A61K 9/107 (2013.01); A61K 9/127 (2013.01); C07K 14/44 (2013.01); C07K 14/445 (2013.01); C07K 16/205 (2013.01); C07K 16/24 (2013.01); A61K 2039/505 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/57 (2013.01); A61K 2039/70 (2013.01); Y02A 50/41 (2018.01); Y02A 50/412 (2018.01);
Abstract

This invention relates to compositions (e.g. vaccine compositions) which can be used to provide a subject with protective immunity against a parasite infection. The compositions comprise: (i) an immunologically effective amount of a nucleic acid (e.g. a nucleic acid-based vaccine) comprising a sequence which encodes a parasite macrophage migration inhibitory factor (MIF) antigen; (ii) a parasite MIF antigen; or (iii) an antibody which specifically binds to a parasite MIF antigen. The compositions may be used to treat infections and diseases caused by parasitic protozoans, such as aparasite, or parasitic helminths.


Find Patent Forward Citations

Loading…